Last reviewed · How we verify

NCT06217068

Comparative Analysis of Biomarkers in Response to Acute Moderate-Intensity Activity

Completed Phase 1, PHASE2 Last updated 20 February 2025
What this trial tests

Phase 1, PHASE2 trial testing Elliptical Activity in Acute Exercise in 9 participants. Completed in 7 February 2025.

Timeline
11 March 2024
Primary endpoint
7 February 2025
7 February 2025

Quick facts

Lead sponsorUniversity of Georgia
PhasePhase 1, PHASE2
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment9
Start date11 March 2024
Primary completion7 February 2025
Estimated completion7 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Georgia

Who can join

Adults 18 to 34, any sex, with Acute Exercise or Aerobic Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to understand how college students' biomarkers change with a relatively short bout of moderate-intensity physical activity. The investigators are comparing biomarkers in between self-reported physically active and sedentary students in terms of their percent difference and change. The investigators are also studying physically active versus sedentary college students' mental health. This is a mentored student research project in the investigator's lab (not part of a thesis, dissertation, or other coursework requirements), where multiple students have developed research questions using the same study design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Exercise

Currently open trials in the same condition.

Other University of Georgia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06217068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing